98 related articles for article (PubMed ID: 3294522)
21. The incretin effect does not differ in trained and untrained, young, healthy men.
Lund MT; Dalby S; Hartmann B; Helge J; Holst JJ; Dela F
Acta Physiol (Oxf); 2014 Mar; 210(3):565-72. PubMed ID: 24354574
[TBL] [Abstract][Full Text] [Related]
22. Discrepant performance on oral and intravenous glucose tolerance tests: the role of gastric inhibitory polypeptide.
Elahi D; Andersen DK; Tobin JD; Andres R
J Clin Endocrinol Metab; 1981 Jun; 52(6):1199-203. PubMed ID: 7014599
[TBL] [Abstract][Full Text] [Related]
23. Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion.
Hampton SM; Morgan LM; Tredger JA; Cramb R; Marks V
Diabetes; 1986 May; 35(5):612-6. PubMed ID: 3514335
[TBL] [Abstract][Full Text] [Related]
24. Incretin effect due to increased secretion and decreased clearance of insulin in normal humans.
Shuster LT; Go VL; Rizza RA; O'Brien PC; Service FJ
Diabetes; 1988 Feb; 37(2):200-3. PubMed ID: 3292314
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal hormones and cortisol in normal pregnant women and women with gestational diabetes.
Hornnes PJ; Kühl C
Acta Endocrinol Suppl (Copenh); 1986; 277():24-6. PubMed ID: 3464150
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males.
Wu T; Rayner CK; Watson LE; Jones KL; Horowitz M; Little TJ
Peptides; 2017 Sep; 95():124-127. PubMed ID: 28800948
[TBL] [Abstract][Full Text] [Related]
27. The differential effect of intragastric and intravenous tryptophan on plasma glucose, insulin, glucagon, GLI and GIP in the fasted rat.
Tsiolakis D; Marks V
Horm Metab Res; 1984 May; 16(5):226-9. PubMed ID: 6376308
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal peptide profile in children with celiac disease.
Hernanz A; Polanco I; Codoceo R; Lama R; Vazquez C
J Pediatr Gastroenterol Nutr; 1987; 6(3):341-5. PubMed ID: 2892903
[TBL] [Abstract][Full Text] [Related]
29. Neurotensin infusion in man: pharmacokinetics and effect on gastrointestinal and pituitary hormones.
Blackburn AM; Fletcher DR; Adrian TE; Bloom SR
J Clin Endocrinol Metab; 1980 Dec; 51(6):1257-61. PubMed ID: 7002947
[TBL] [Abstract][Full Text] [Related]
30. Circulating gastrointestinal hormones in patients with flatulent dyspepsia, with and without gallbladder disease.
Watson RG; Shaw C; Buchanan KD; Love AH
Digestion; 1986; 35(4):211-6. PubMed ID: 3545953
[TBL] [Abstract][Full Text] [Related]
31. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
Ross SA; Dupre J
Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
[TBL] [Abstract][Full Text] [Related]
32. Gastric inhibitory polypeptide and insulin: response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs.
Kühl C; Hornnes PJ; Jensen SL; Lauritsen KB
Endocrinology; 1980 Nov; 107(5):1446-50. PubMed ID: 7000494
[TBL] [Abstract][Full Text] [Related]
33. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
Gilor C; Graves TK; Gilor S; Ridge TK; Weng HY; Dossin O
Domest Anim Endocrinol; 2011 May; 40(4):205-12. PubMed ID: 21397435
[TBL] [Abstract][Full Text] [Related]
34. Insulin-lowering effect of phenformin not mediated by inhibition of gastric inhibitory polypeptide.
Schmitt JK; Brown JC; Karam JH
Proc Soc Exp Biol Med; 1979 Jan; 160(1):63-4. PubMed ID: 368813
[No Abstract] [Full Text] [Related]
35. Diminished gastric inhibitory polypeptide response to oral glucose in late human pregnancy.
Hornnes PJ; Kühl C; Lauritsen KB
J Clin Endocrinol Metab; 1979 Mar; 48(3):506-8. PubMed ID: 429501
[TBL] [Abstract][Full Text] [Related]
36. Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man.
Adrian TE; Sagor GR; Savage AP; Bacarese-Hamilton AJ; Hall GM; Bloom SR
J Clin Endocrinol Metab; 1986 Oct; 63(4):803-7. PubMed ID: 3755728
[TBL] [Abstract][Full Text] [Related]
37. The effect of parenteral and enteral nutrition on portal and systemic immunoreactivities of gastrin, glucagon and vasoactive intestinal polypeptide (VIP).
Gimmon Z; Murphy RF; Chen MH; Nachbauer CA; Fischer JE; Joffe SN
Ann Surg; 1982 Nov; 196(5):571-5. PubMed ID: 6812513
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal hormones and short-term nutritional schedules in critically ill patients.
Mandragos C; Moukas M; Amygdalou A; Schulpis K; Dalavanga YA; Behrakis PK; Vassiliou MP
Hepatogastroenterology; 2003; 50(53):1442-5. PubMed ID: 14571758
[TBL] [Abstract][Full Text] [Related]
39. Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose.
Madsbad S; Kehlet H; Hilsted J; Tronier B
Diabetes; 1983 May; 32(5):436-8. PubMed ID: 6341127
[TBL] [Abstract][Full Text] [Related]
40. Diurnal profiles of gastrointestinal regulatory peptides.
Jorde R; Burhol PG
Scand J Gastroenterol; 1985 Jan; 20(1):1-4. PubMed ID: 2859649
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
